At Shire, he had been head of global regulatory affairs, global drug safety and R&D quality and compliance. Now, it’s losing Howard Mayer, M.D., Shire’s ex-senior vice president, chief medical ...

For decades, the sunbaked fields of the Shire Valley districts of Chikwawa and Nsanje have watched clouds pass with empty ...

> Sanofi-Aventis' takeover of Genzyme would not upset the high-margin market in drugs for rare diseases, given the specialized nature of the business, Shire's chief executive says. Story > Teva ...